Writer for http://InvestorPlace.com. I cover a variety of shares with a focus on meme and Reddit stocks, as well as crypto. I don't offer financial advice.
United States (National)
Not enough data
Not enough data
William's focus is on investment analysis, particularly in the stock market and cryptocurrency. His coverage heavily relies on data citations, suggesting he prioritizes statistical evidence and factual information.
Given his focus on analyzing stock movements and trends, William would likely be interested in pitches from financial analysts who can provide insights into why specific stocks or crypto assets are experiencing notable changes. Sources with access to real-time data or those who can interpret market trends intelligently may also find success when pitching to him.
As William does not have a specified geographic focus, sources providing relevant insights into global financial markets could make valuable contributions to his coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Edible Garden stock is up on Wednesday alongside heavy trading of EDBL shares after the company posted its Q2 earnings report.
Flutter Entertainment stock is up on Wednesday as FLUT investors celebrate the company beating Wall Street's estimates for Q2.
By: William White
VSME and TSBX are leading our pre-market stock movers this morning
VS Media ( VSME ) stock is up on Thursday alongside heavy pre-market trading.
SciSparc stock is up on Thursday with heavy trading of SPRC shares after it provided an update on its merger with AutoMax.
Turnstone Biologics stock is down on Thursday as TSBX investors react to the company missing estimates for Q2.
By: Rui Che, Monireh Panah, Bhoomi Mirani, Krista Knowles, Anastacia Ostapovich, Debarati Majumdar, Xiaotong Chen, Joseph DeSimone, William White, Megan Noonan, Hong Luo, Andrei Alexandrov Rui Che, Monireh Panah, Bhoomi Mirani, Krista Knowles
Abstract Despite critical roles in diseases, human pathways acting on strictly nuclear non-coding RNAs have been refractory to forward genetics.
By: William White
CERo Therapeutics stock is rising higher on Monday as investors react to the latest preclinical data concerning lead compound CER-1236.
(833) 317-6278 
